Online mindfulness for people diagnosed with cancer (OM-C) study

Not Applicable

Recruiting

• Conditions: cancer; Cancer - Any cancer

• Registration Number: ACTRN12621000392864
• Lead Sponsor: Chris O'Brien Lifehouse

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-04-08
• Last Update Posted: 24 October 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 108

Inclusion Criteria

Any cancer, >6 month life expectancy

Exclusion Criteria

Patients with high scores indicative of clinical levels of anxiety, or depression or a psychiatric diagnosis who are deemed unsuitable following further screening by the psychologist or health care professional

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Acceptability measured using the Acceptability of Intervention Measure[7 weeks (course completion)];Appropriateness measured using the Appropriateness of Intervention Measure[7 weeks (course completion)];Feasibility measured using the Feasibility of Intervention Measure[7 weeks (course completion)]

Secondary Outcome Measures

Name	Time	Method
Cancer symptom burden and severity assessed using the Edmonton Symptom Assessment Scale (ESAS)[Baseline, 7 weeks (course completion)];Depression, anxiety, and stress assessed using the DASS-21[Baseline, 7 weeks (course completion)];Self-management skills assessed using the Health Education Impact Questionnaire[Baseline, 7 weeks (course completion)];Self-efficacy for coping with cancer, assessed using the Cancer Behavior Inventory[Baseline, 7 weeks (course completion)];Mindfulness assessed using the Freiburg Mindfulness Inventory[Baseline, 7 weeks (course completion)];Concerns and wellbeing of people affected by cancer assessed using the Measure Yourself Wellness and Concerns[Baseline, 7 weeks (course completion)]